The U.S. company, which was the first drugmaker to apply for emergency use authorization of its COVID-19 vaccine in the country, had a meeting with India#39;s drugs regulator on Wednesday and the decision was made after that, the company said.from Moneycontrol Business News https://ift.tt/3rBgMXF
No comments:
Post a Comment